Diabeloop is a French healthcare technology company founded in 2015, dedicated to revolutionizing type 1 diabetes management through innovative automated solutions. Its flagship product, the DBLG1 system, is a hybrid closed-loop insulin delivery system that utilizes a self-learning algorithm to adjust insulin doses based on real-time glucose data, optimizing blood sugar levels while reducing the burden of manual management. With over 10,000 users across Europe, Diabeloop emphasizes user-centric design and clinical validation, demonstrating significant improvements in glycemic control. Committed to empowering individuals with diabetes, Diabeloop aims to simplify and enhance diabetes care through cutting-edge technology and continuous innovation.